search icon
  • What's New in Practice Management & Payment

    AMA Releases an Interactive Web-based Tool for MIPS

    CMS Releases 2018 Medicare Physician Fee Schedule Proposed Rule

    CMS: Fact Sheet for the QPP Year 2 Proposed Rule

    AMA Releases New MIPS Resources

    CMS Releases Lookup Tool to Help Clinicians Determine their MIPS Participation Status

  • News from IDSA and Journals


    New Molecular Testing for Infectious Diarrhea Improves Diagnosis


    Advances in molecular testing for infectious diarrhea can improve diagnosis, direct therapy, and guide public health surveillance efforts, according to new guidelines from IDSA.

  • CDC and FDA Alerts

    10/23/2017 1:28:09 PM

    FDA MedWatch - Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination

    SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling various lots of injectable products to the hospital level. 

    10/19/2017 3:04:38 PM

    CDC updates guidance for infants born to mothers with possible Zika virus infection during pregnancy

    The Centers for Disease Control and Prevention (CDC) today issuedupdated interim clinical guidance for health care providers caring for infants born to mothers with possible Zika virus infection during pregnancy.

    10/5/2017 6:54:35 PM

    FDA approves first test for screening Zika virus in blood donations

    FDA approves first test for screening Zika virus in blood donations The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors. 

    10/4/2017 1:14:59 PM

    Potentially blinding complication following intraocular injections of compounded vancomycin formulation - Drug Information Update

    Hemorrhagic occlusive retinal vasculitis (HORV) is a rare, potentially blinding postoperative complication that has been observed in dozens of patients who have received intraocular injections of vancomycin (anti-infective) formulations toward the end of otherwise uncomplicated cataract surgeries.

    9/29/2017 5:00:42 PM

    Candida auris Clinical Update- September 2017

    Candida auris is an emerging, multidrug-resistant yeast that causes invasive infections and is transmitted in healthcare settings.

    10/4/2017 11:49:50 AM

    FDA approves new drug for bacterial vaginosis

    Today FDA approved a new medication for bacterial vaginosis. This treatment is the first one-dose oral regimen for the most common vaginal infection in women 15-44 years of age.

    9/13/2017 4:53:22 PM

    Rifampin/Penicillin-Resistant Strain of RB51 Brucella Contracted from Consumption of Raw Milk

    The Texas Department of State Health Services, with assistance from CDC, is investigating Brucella RB51 exposures and illnesses that may be connected to the purchase and consumption of raw (unpasteurized) milk from K-Bar Dairy in Paradise, Texas.

    9/12/2017 3:15:14 PM

    Tetanus in Areas Affected by a Hurricane: Risk, Prevention, and Management Guidelines for Clinicians

    Exposure to flood waters does not increase the risk of tetanus. Therefore, tetanus immunization campaigns for evacuees from flooding disasters are not needed. 

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site